Summary
Boston Scientific Corporation (BSX) filed its Form 10-Q for the quarterly period ended June 30, 2001. This report provides a snapshot of the company's financial position and operational status during this period. Investors should note that the filing is primarily a procedural update, confirming the company has met its filing obligations for the preceding 12 months and the past 90 days. The report also details the number of common shares outstanding as of June 30, 2001, which stood at 402,405,387. As this is a quarterly report, a detailed breakdown of financial performance metrics like revenue, net income, and specific segment performances is not immediately available within the provided excerpt. However, the confirmation of regular filings indicates continued compliance with SEC regulations. Investors seeking in-depth financial analysis will need to refer to the full report and accompanying financial statements, which typically include a Management's Discussion and Analysis (MD&A) section for a more comprehensive understanding of the company's results and outlook.
Key Highlights
- 1Boston Scientific Corporation (BSX) filed its Form 10-Q for the quarter ending June 30, 2001.
- 2The company confirms it has filed all required reports for the preceding 12 months and the past 90 days.
- 3As of June 30, 2001, Boston Scientific had 402,405,387 shares of common stock outstanding.
- 4This filing serves as a confirmation of ongoing regulatory compliance.
- 5The excerpt does not contain detailed financial performance figures for the quarter.